mRNA-LNP Critical Quality Attribute Analytics Market
完整報告名稱與涵蓋範圍
mRNA-LNP Critical Quality Attribute Analytics Market Size, Share & Trends Analysis Report, By Instrument Platform (Liquid Chromatography and Mass Spectrometry Systems, Capillary and Microfluidic Electrophoresis, Light Scattering, Nanoparticle Tracking and Particle Sizing, Digital PCR, Sequencing and Fluorescence-Based Assays), By Attribute Measured (RNA Integrity, Sequence and Purity, Capping and Poly(A) Tail Characterization, Encapsulation Efficiency, Particle Size and Lipid Composition, Potency and Expression), By Offering (Instruments, Consumables, Kits and Reference Standards, Software and Data Analysis), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The mRNA-LNP critical quality attribute analytics market covers instruments, consumables, reference standards and software used by manufacturers and laboratories to measure the quality attributes of messenger RNA and lipid nanoparticle products, including RNA integrity and purity, cap and tail structure, encapsulation efficiency, particle size and lipid composition and potency. Contract testing services are addressed in a separate InsightAce study and excluded here.
Analytical instrumentation has become a strategic investment for RNA manufacturers because regulators require orthogonal, validated methods for attributes that conventional biologics platforms were not designed to measure, and because process development depends on rapid feedback. Vendors are adapting liquid chromatography, mass spectrometry, capillary electrophoresis and light scattering platforms with RNA-specific columns, consumables and software workflows, introducing automated systems for tail-length and cap analysis and offering multi-attribute methods that compress release panels. Digital PCR and sequencing address sequence fidelity, while cell-based and cell-free expression assays measure potency; reference standards and system suitability materials are emerging to harmonise results across laboratories.
North America and Europe lead purchasing, with Asia Pacific growing as RNA manufacturing and quality laboratories expand in China, South Korea, Japan and Singapore. Competition involves analytical instrument leaders, particle characterisation specialists and bioprocess groups bundling analytics with manufacturing platforms.
The InsightAce study provides US$ revenue forecasts for every instrument platform, attribute measured, offering and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global mRNA-LNP Critical Quality Attribute Analytics Market Snapshot
Chapter 4. Global mRNA-LNP Critical Quality Attribute Analytics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Instrument Platform Estimates & Trend Analysis
5.1. Instrument Platform & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Instrument Platform:
5.2.1. Liquid Chromatography and Mass Spectrometry Systems
5.2.2. Capillary and Microfluidic Electrophoresis
5.2.3. Light Scattering, Nanoparticle Tracking and Particle Sizing
5.2.4. Digital PCR, Sequencing and Fluorescence-Based Assays
Chapter 6. Market Segmentation 2: By Attribute Measured Estimates & Trend Analysis
6.1. Attribute Measured & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Attribute Measured:
6.2.1. RNA Integrity, Sequence and Purity
6.2.2. Capping and Poly(A) Tail Characterization
6.2.3. Encapsulation Efficiency, Particle Size and Lipid Composition
6.2.4. Potency and Expression
Chapter 7. Market Segmentation 3: By Offering Estimates & Trend Analysis
7.1. Offering & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Offering:
7.2.1. Instruments
7.2.2. Consumables, Kits and Reference Standards
7.2.3. Software and Data Analysis
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. mRNA Developers and Manufacturers
8.2.2. CDMOs and Contract Laboratories
8.2.3. Academic and Research Institutes
Chapter 9. mRNA-LNP Critical Quality Attribute Analytics Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. Agilent Technologies, Inc.
11.2. Waters Corporation (Wyatt Technology)
11.3. SCIEX (Danaher)
11.4. Thermo Fisher Scientific Inc.
11.5. Malvern Panalytical Ltd.
11.6. Bio-Rad Laboratories, Inc.
11.7. Bruker Corporation
11.8. Shimadzu Corporation
11.9. Sartorius AG
11.10. Unchained Labs
11.11. Particle Metrix GmbH
11.12. Nicoya Lifesciences Inc.
11.13. Refeyn Ltd.
11.14. Cytiva (Danaher)
11.15. ProteinSimple (Bio-Techne Corporation)
圖表清單 List of Tables & Figures
Table 1. Global mRNA-LNP Critical Quality Attribute Analytics Market Revenue Forecast by Instrument Platform, 2026-2035 (US$ Mn)
Figure 1. Global mRNA-LNP Critical Quality Attribute Analytics Market Segmentation and Scope Overview
Table 2. Global mRNA-LNP Critical Quality Attribute Analytics Market Revenue Forecast by Attribute Measured, 2026-2035 (US$ Mn)
Figure 2. Global mRNA-LNP Critical Quality Attribute Analytics Market Share by Instrument Platform, 2026 & 2035
Table 3. Global mRNA-LNP Critical Quality Attribute Analytics Market Revenue Forecast by Offering, 2026-2035 (US$ Mn)
Figure 3. Orthogonal Analytical Methods Mapped to mRNA-LNP Critical Quality Attributes
Table 4. Global mRNA-LNP Critical Quality Attribute Analytics Market Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Instrument Investment per RNA Manufacturing Site by Analytical Function
Table 5. Global mRNA-LNP Critical Quality Attribute Analytics Market Revenue Forecast by Region, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific mRNA-LNP Critical Quality Attribute Analytics Growth Opportunity Analysis
Table 6. North America mRNA-LNP Critical Quality Attribute Analytics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Competitive Positioning of Key mRNA-LNP Critical Quality Attribute Analytics Market Participants
Table 7. Europe mRNA-LNP Critical Quality Attribute Analytics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Porter's Five Forces Analysis of the Global mRNA-LNP Critical Quality Attribute Analytics Market
Table 8. Asia Pacific mRNA-LNP Critical Quality Attribute Analytics Market Revenue by Country, 2026-2035 (US$ Mn)
Figure 8. Multi-Attribute Method Adoption and Its Effect on Release Testing Panels
Table 9. Strategic Developments of Leading mRNA-LNP Critical Quality Attribute Analytics Market Participants, 2023-2026
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們